Prognostic impact of discordance in hormone receptor status after the neoadjuvant chemotherapy in primary breast cancer

被引：0
|
作者：
Kurihara, Toshiaki [1 ]
Ueno, Hanako [1 ]
Takemae, Masaru [1 ]
Nagayama, Aiko [1 ]
Takahashi, Maiko [1 ]
Hayashida, Tetsu [1 ]
Jinno, Hiromitsu [1 ]
Kitagawa, Yuko [1 ]
机构：
[1] Keio Univ, Sch Med, Tokyo 108, Japan
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.SABCS14-P3-06-49
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-06-49
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Clinical significance and prognostic value of receptor conversion in hormone receptor positive breast cancers after neoadjuvant chemotherapy
    Libo Yang
    Xiaorong Zhong
    Tianjie Pu
    Yan Qiu
    Feng Ye
    Hong Bu
    World Journal of Surgical Oncology, 16
  • [32] Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer
    Liedtke, C.
    Broglio, K.
    Moulder, S.
    Hsu, L.
    Kau, S. -W.
    Symmans, W. F.
    Albarracin, C.
    Meric-Bernstam, F.
    Woodward, W.
    Theriault, R. L.
    Kiesel, L.
    Hortobagyi, G. N.
    Pusztai, L.
    Gonzalez-Angulo, A. M.
    ANNALS OF ONCOLOGY, 2009, 20 (12) : 1953 - 1958
  • [33] Different prognostic impact according to residual tumour status after neoadjuvant chemotherapy in breast cancer sub-types
    Wada, N.
    Yoneyama, K.
    Yamauchi, C.
    Kang, Y.
    Okada, T.
    Fujii, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S191 - S191
  • [34] Prognostic implications of receptor discordance between primary and recurrent breast cancer
    Matsumoto, Akiko
    Jinno, Hiromitsu
    Murata, Takeshi
    Seki, Tomoko
    Takahashi, Maiko
    Hayashida, Tetsu
    Kameyama, Kaori
    Kitagawa, Yuko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (04) : 701 - 708
  • [35] Prognostic implications of receptor discordance between primary and recurrent breast cancer
    Akiko Matsumoto
    Hiromitsu Jinno
    Takeshi Murata
    Tomoko Seki
    Maiko Takahashi
    Tetsu Hayashida
    Kaori Kameyama
    Yuko Kitagawa
    International Journal of Clinical Oncology, 2015, 20 : 701 - 708
  • [36] Receptor discordance after neoadjuvant chemotherapy with pembrolizumab in early-stage triple-negative breast cancer
    LeVee, Alexis
    Wong, Megan
    Flores, Sarah
    Ruel, Nora
    McArthur, Heather
    Waisman, James
    Mortimer, Joanne
    CANCER RESEARCH, 2024, 84 (09)
  • [37] Impact of progesterone receptor status on response to neoadjuvant chemotherapy in oestrogen receptor positive breast cancer patients
    Boland, Michael R.
    Ryan, Eanna J.
    Nugent, Timothy
    Gilroy, Darina
    Kennedy, John
    Alazawi, Dhaffir
    Boyle, Terence J.
    Connolly, Elizabeth M.
    CANCER RESEARCH, 2020, 80 (04)
  • [38] Impact of neoadjuvant chemotherapy on surgical outcomes among patients with hormone receptor positive breast cancer
    Hage, Andrew N.
    Capriccioso, Christina
    Brennan, Julia
    Heiden, Brendan
    Zheutlin, Alexander
    Sabel, Michael S.
    JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (06) : 665 - 670
  • [39] Association of residual ductal carcinoma in situ with breast cancer treatment outcomes after neoadjuvant chemotherapy according to hormone receptor status
    Shin, Eunju
    Yoo, Tae-Kyung
    Kim, Jisun
    Chung, Il Yong
    Ko, Beom Seok
    Kim, Hee Jeong
    Lee, Jong Won
    Son, Byung Ho
    Lee, Sae Byul
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [40] Clinical significance and prognostic value of receptor conversion after neoadjuvant chemotherapy in breast cancer patients
    He, Yang
    Zhang, Jing
    Chen, Hui
    Zhou, Ying
    Hong, Liping
    Ma, Yue
    Chen, Nannan
    Zhao, Weipeng
    Tong, Zhongsheng
    FRONTIERS IN SURGERY, 2023, 9
12345